• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人镰状细胞病慢性疼痛患者的特征和潜在生物标志物。

Characteristics and potential biomarkers of adult sickle cell patients with chronic pain.

机构信息

Medical College of Georgia at Augusta University, Augusta, GA, USA.

Center for Blood Disorders Medical College of Georgia at Augusta University, Augusta, GA, USA.

出版信息

Eur J Haematol. 2020 Oct;105(4):419-425. doi: 10.1111/ejh.13461. Epub 2020 Jul 1.

DOI:10.1111/ejh.13461
PMID:32497305
Abstract

OBJECTIVES

In this study, we investigated the evolution of chronic pain in sickle cell patients (SCD) as an age-dependent phenomenon and studied the frequency of vaso-occlusive episode frequency, opioid use, quantitative sensory testing (QST), and biomarkers of chronic pain (CP).

METHODS

We undertook a cross-sectional study of the evolution of CP in SCD. A total of 72 subjects (age 15-66) were enrolled. VOE frequency, presence of CP hydroxyurea (HU) therapy, opioid use, and laboratory parameters were collected. QST was performed, and plasma tryptase, substance P, and NGF (Nerve Growth Factor) levels were assayed.

RESULTS

There was an age-dependent increase in frequency of CP, VOEs, opioid use, and Von Frey monofilament values. CP patients had significantly higher opioid use (daily morphine equivalents) (52.8 mg vs 6.94 mg, P = .009), suggesting a correlation between opioid use and hyperalgesia. NGF levels were also significantly higher (P = .051). Our results confirm previous observations of an age-dependent increase in the proportion of patients with CP and support the contributing role of mast cell activation and neurogenic inflammation.

CONCLUSIONS

This is the first study of NGF as a possible biomarker of CP in SCD. If confirmed, this could provide a diagnostic marker and therapeutic target for CP in SCD.

摘要

目的

本研究旨在探讨镰状细胞病(SCD)患者慢性疼痛随年龄增长而演变的现象,并研究血管阻塞性发作频率、阿片类药物使用、定量感觉测试(QST)和慢性疼痛(CP)的生物标志物的频率。

方法

我们进行了一项 SCD 患者 CP 演变的横断面研究。共纳入 72 名年龄在 15-66 岁的受试者。收集 VOE 频率、CP 羟基脲(HU)治疗、阿片类药物使用和实验室参数。进行 QST,并测定血浆胰蛋白酶、P 物质和 NGF(神经生长因子)水平。

结果

CP、VOE、阿片类药物使用和 Von Frey 单丝值随年龄呈依赖性增加。CP 患者阿片类药物使用(每日吗啡当量)显著更高(52.8mg 比 6.94mg,P=0.009),表明阿片类药物使用与痛觉过敏之间存在相关性。NGF 水平也明显更高(P=0.051)。我们的结果证实了以前观察到的 CP 患者比例随年龄增长而增加的观察结果,并支持肥大细胞激活和神经源性炎症的致病作用。

结论

这是首次研究 NGF 作为 SCD 中 CP 的潜在生物标志物。如果得到证实,这可能为 SCD 中的 CP 提供诊断标志物和治疗靶点。

相似文献

1
Characteristics and potential biomarkers of adult sickle cell patients with chronic pain.成人镰状细胞病慢性疼痛患者的特征和潜在生物标志物。
Eur J Haematol. 2020 Oct;105(4):419-425. doi: 10.1111/ejh.13461. Epub 2020 Jul 1.
2
Characteristics of sickle cell patients with frequent emergency department visits and hospitalizations.频繁前往急诊科就诊和住院的镰状细胞病患者的特征。
PLoS One. 2021 Feb 22;16(2):e0247324. doi: 10.1371/journal.pone.0247324. eCollection 2021.
3
Score Predicting Acute Chest Syndrome During Vaso-occlusive Crises in Adult Sickle-cell Disease Patients.预测成年镰状细胞病患者血管闭塞性危象期间急性胸综合征的评分
EBioMedicine. 2016 Aug;10:305-11. doi: 10.1016/j.ebiom.2016.06.038. Epub 2016 Jun 29.
4
Chronic Pain Does Not Impact Baseline Circulating Cytokine Levels in Adults with Sickle Cell Disease.慢性疼痛不会影响镰状细胞病成人的基线循环细胞因子水平。
Acta Haematol. 2021;144(1):111-116. doi: 10.1159/000507563. Epub 2020 May 13.
5
Sex-based differences in the manifestations and complications of sickle cell disease: Report from the Sickle Cell Disease Implementation Consortium.镰状细胞病表现和并发症的性别差异:镰状细胞病实施联盟报告。
PLoS One. 2021 Oct 29;16(10):e0258638. doi: 10.1371/journal.pone.0258638. eCollection 2021.
6
Dexmedetomidine as an Adjuvant to Analgesic Strategy During Vaso-Occlusive Episodes in Adolescents with Sickle-Cell Disease.右美托咪定作为镰状细胞病青少年血管闭塞发作期间镇痛策略的辅助用药
Pain Pract. 2015 Nov;15(8):E90-7. doi: 10.1111/papr.12336. Epub 2015 Jul 23.
7
Patient characteristics affect the response to ketamine and opioids during the treatment of vaso-occlusive episode-related pain in sickle cell disease.患者特征会影响镰状细胞病血管阻塞性发作相关疼痛治疗中对氯胺酮和阿片类药物的反应。
Pediatr Res. 2018 Feb;83(2):445-454. doi: 10.1038/pr.2017.197. Epub 2017 Sep 13.
8
Characterization of opioid use in sickle cell disease.镰状细胞病中阿片类药物使用情况的特征分析。
Pharmacoepidemiol Drug Saf. 2018 May;27(5):479-486. doi: 10.1002/pds.4291. Epub 2017 Aug 16.
9
Plasma PTX3 levels in sickle cell disease patients, during vaso occlusion and acute chest syndrome (data from Saudi population).镰状细胞病患者在血管闭塞和急性胸部综合征期间的血浆PTX3水平(来自沙特人群的数据)
Hematology. 2014 Jan;19(1):52-9. doi: 10.1179/1607845413Y.0000000092. Epub 2013 Nov 25.
10
New and emerging treatments for vaso-occlusive pain in sickle cell disease.镰状细胞病血管阻塞性疼痛的新疗法和新出现的疗法。
Expert Rev Hematol. 2019 Oct;12(10):857-872. doi: 10.1080/17474086.2019.1649131. Epub 2019 Aug 6.

引用本文的文献

1
Buprenorphine Is Associated With Lower Home Opioid Use and Acute Care Utilization in Sickle Cell Disease.丁丙诺啡与镰状细胞病患者较低的家庭阿片类药物使用及急性护理利用率相关。
Pain Manag Nurs. 2025 May 29. doi: 10.1016/j.pmn.2025.04.012.
2
Targeting sickle cell pathobiology and pain with novel transdermal curcumin.用新型透皮姜黄素靶向镰状细胞病理生物学和疼痛。
PNAS Nexus. 2025 Feb 13;4(2):pgaf053. doi: 10.1093/pnasnexus/pgaf053. eCollection 2025 Feb.
3
A bone to pick-cellular and molecular mechanisms of bone pain in sickle cell disease.
棘手问题——镰状细胞病骨痛的细胞和分子机制
Front Pain Res (Lausanne). 2024 Jan 4;4:1302014. doi: 10.3389/fpain.2023.1302014. eCollection 2023.
4
Altered pain processing and sensitization in sickle cell disease: a scoping review of quantitative sensory testing findings.镰状细胞病中疼痛处理和敏化的改变:定量感觉测试结果的范围综述。
Pain Med. 2024 Feb 1;25(2):144-156. doi: 10.1093/pm/pnad133.
5
Digital behavioural interventions for people with sickle cell disease.针对镰状细胞病患者的数字行为干预措施。
Cochrane Database Syst Rev. 2021;2021(4). doi: 10.1002/14651858.CD014669. Epub 2021 Apr 27.
6
Pain in sickle cell disease: current and potential translational therapies.镰状细胞病的疼痛:当前和潜在的转化治疗方法。
Transl Res. 2021 Aug;234:141-158. doi: 10.1016/j.trsl.2021.03.007. Epub 2021 Mar 9.
7
Considerations for Cannabis Use to Treat Pain in Sickle Cell Disease.关于使用大麻治疗镰状细胞病疼痛的考量
J Clin Med. 2020 Dec 1;9(12):3902. doi: 10.3390/jcm9123902.
8
Scalable in silico Simulation of Transdermal Drug Permeability: Application of BIOiSIM Platform.可扩展的经皮药物渗透的计算模拟:BIOiSIM 平台的应用。
Drug Des Devel Ther. 2020 Jun 11;14:2307-2317. doi: 10.2147/DDDT.S253064. eCollection 2020.